(19)
(11) EP 1 513 921 A1

(12)

(43) Date of publication:
16.03.2005 Bulletin 2005/11

(21) Application number: 03722086.0

(22) Date of filing: 30.05.2003
(51) International Patent Classification (IPC)7C12M 1/42, C12N 5/12, C12N 5/16, C12N 5/28, C12N 13/00, A61K 48/00, A61K 35/54
(86) International application number:
PCT/AU2003/000666
(87) International publication number:
WO 2003/102126 (11.12.2003 Gazette 2003/50)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
Designated Extension States:
AL LT LV MK

(30) Priority: 31.05.2002 US 384882 P
07.06.2002 US 387284 P
19.06.2002 AU PS307802
05.09.2002 AU 2002951222
05.09.2002 AU 2002951223

(71) Applicant: Apollo Life Sciences Pty Ltd.
Balmain, NSW 2041 (AU)

(72) Inventors:
  • NURCOMBE, Victor
    Chapel Hill, QLD 4069 (AU)
  • MONAGHAN, David, Robert, James
    Botany, NSW 2019 (AU)
  • CAMPBELL, Douglas, Hamish
    Drummoyne, NSW 2047 (AU)
  • PRIEST, John, Daniel
    Balmain, NSW 2041 (AU)
  • WATTS, Alan, Douglas
    Dee Why, NSW 2099 (AU)

(74) Representative: Gardner, Rebecca 
Frank B. Dehn & Co.179 Queen Victoria Street
London EC4V 4EL
London EC4V 4EL (GB)

   


(54) A METHOD OF CELL THERAPY USING FUSED CELL HYBRIDS